BuzzSparks.org

Amyris Biotechnologies


Renewable Fuels

Amyris Biotechnologies creates renewable products, focusing on fuels and chemicals. The company plans to enter the market by 2011. The company is developing renewable fuels that reduce lifecycle (GHG) emissions 80%. The fuel source is special in...

Homepage:
Total money raised: $308.6M

94608 5885 Hollis Street, Suite 100

Emeryville
USA CA

Phone: (510) 450-0761

Updated on Feb 27, 2012
Amyris Biotechnologies at CrunchBase
Tags:   chemicals   cleantech   fuels   malaria   malaria-treatment   renewable   renewable-chemicals   renewable-fuels   treatment

Arthur D. Levinson Board of Directions
Past

February, 2012

Amyris Biotechnologies raised $83.7M in unattributed round

Amyris Secures $83.7 Million in Additional Financing    businesswire.com

November, 2011

Amyris Biotechnologies acquired Draths Corporation

Amyris Acquires Draths    chemweek.com

July, 2010

Amyris Biotechnologies raised $47.8M in a Series D round from Temasek

Amyris Biotechnologies, Inc.: Series D $47.8M    onbiovc.com

June, 2010

Amyris Enters Into Multi-Products Collaboration and Off-Take Agreements with The Procter and Gamble Company    amyrisbiotech.com

December, 2009

Amyris Biotechnologies raised $24.3M in grant round

SEC Filing Via Liquid Scenarios Search2Model    liquidscenarios.com

October, 2009

Amyris Biotechnologies raised $41.8M in a Series C round from Kleiner Perkins Caufield & Byers, Khosla Ventures, TPG Growth, and Votorantim Novos Negocios

Amyris Closes in on $60M Round for Synthetic Diesel    earth2tech.com

August, 2008

Amyris Biotechnologies raised $21M in a Series B round from DAG Ventures, Khosla Ventures, Kleiner Perkins Caufield & Byers, and TPG Growth

Amyris Picks Up Another $21M For Synthetic Bio    earth2tech.com

September, 2007

Amyris Biotechnologies raised $70M in a Series B round from DAG Ventures, Khosla Ventures, Kleiner Perkins Caufield & Byers, and TPG Growth

Amyris Announces $70 Million Series B Round    amyris.com

October, 2006

Amyris Biotechnologies raised $20M in a Series A round from Khosla Ventures, Kleiner Perkins Caufield & Byers, and TPG Growth

Amyris gets $20M from high-profile investors to find alternative fuel    venturebeat.com